Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease
Gaucher disease (OMIM #230800) is caused by β-glucosidase deficiency and primarily involves the mononuclear phagocyte system (also called Reticuloendothelial System or Macrophage System). The disease is classified into three main phenotypes based on the presence or absence of neurological manifestat...
Main Authors: | A.A. Mhanni, M. Kozenko, J.N. Hartley, M. Deneau, W. El-Matary, C. Rockman-Greenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Molecular Genetics and Metabolism Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426915300574 |
Similar Items
-
Developing markers of neurological manifestations in Neuronopathic Gaucher Disease
by: Davies, E. H.
Published: (2011) -
Intravenously administered gene therapy for neuronopathic Gaucher disease
by: Massaro, Giulia
Published: (2018) -
Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse.
by: Ying Sun, et al.
Published: (2011-04-01) -
Protein-losing enteropathy
by: A I Parfenov, et al.
Published: (2017-02-01) -
Enhanced calcium release in the acute neuronopathic form of Gaucher disease
by: Dori Pelled, et al.
Published: (2005-02-01)